Medical imaging and radiology
Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryRetInSight Fluid Monitor medical AI product profile
CE-marked Class IIa clinical decision-support software that quantifies retinal fluid biomarkers in OCT scans for neovascular age-related macular degeneration monitoring.
Medical imaging and radiology
Best fit
Retina clinics that need reproducible OCT fluid quantification and longitudinal visualization to support specialist-reviewed nAMD management.
- Primary use case
- AI-based OCT retinal-fluid segmentation, quantification, visualization, follow-up charts, and nAMD monitoring support
- Audience
- Retina specialists, ophthalmology clinics, nAMD treatment teams, and OCT workflow leaders
- Risk level
- High
- Pricing signal
- Specialist-clinic and enterprise pricing varies by integration and region; request current availability, licensing, and device-status terms.
- Official sources
- 3 official sources
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating RetInSight Fluid Monitor as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Verify current MDR/CE status, local availability, intended nAMD use, OCT compatibility, and whether any U.S. use is investigational, research-only, or otherwise restricted. |
|---|---|
| Privacy | Review OCT upload, cloud or local processing, patient identifiers in reports, retention, user access, export controls, support access, and clinic data-processing terms. |
| Evidence | Validate segmentation and volumetric trends against specialist review for local OCT devices, scan quality, disease severity, treatment intervals, and fluid types. |
| Workflow | Best governed as retina-specialist-reviewed OCT quantification and monitoring support, with documented override rules and treatment decisions made outside the algorithm. |
Where RetInSight Fluid Monitor fits
RetInSight describes Fluid Monitor as software for nAMD that automatically visualizes and quantifies IRF, SRF, and PED on OCT, produces follow-up charts, and meets MDR 2017/745 Class IIa medical-device requirements; company materials describe CE marking for an AI-based clinical decision-support system.
Not for: Standalone diagnosis, treatment decisions without retina-specialist interpretation, non-nAMD workflows, or use outside cleared/available regions.
What to verify before using RetInSight Fluid Monitor
- Current CE/MDR status, country availability, version, indication, OCT device compatibility, and whether U.S. clinical use is supported.
- Which fluid types, retinal layers, scans, and report outputs are validated for the target nAMD workflow.
- How OCT images, reports, patient identifiers, cloud processing, local integration, retention, and support access are governed.
- How retina specialists review quantified fluid outputs, handle segmentation errors, and document treatment decisions.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.retinsight.com / ai-in-clinical-routine / fluid-monitor
- www.retinsight.com / news / retinsight-fluid-monitor-provides-next-evolutionary-step-in-monitoring-of-neovascular-age-related-macular-degeneration
- www.retinsight.com
Related medical AI products
Medical imaging and radiology
Viz.ai
AI-powered care coordination platform with imaging-driven alerts across therapeutic areas.
Medical imaging and radiology
Ferrum Health
Clinical AI governance and deployment platform for health systems adopting multiple imaging or clinical AI models.
Medical imaging and radiology
Blackford Platform
Enterprise medical imaging AI platform for evaluating, deploying, routing, and monitoring multiple radiology AI applications.